Hong Kong needs new funding model to attract global drug makers: AstraZeneca
- Posted on October 1, 2026
- By South China Morning Post
- 1 Views
- 1 min read
In brief
Generating AI summary…
Hong Kong needs new funding model to attract global drug makers: AstraZeneca
The pharmaceutical giant has conducted more than 60 clinical trials worth US$25.5 million in the city over the last three years.